News
We’re pleased to announce the publication, in Pharmaceutical Medicine, of another piece of our game-changing original #research in medical affairs and pharmaceuticals strategy.
Development and use of a post-acute COVID-19 quality of life patient-reported outcome measure – the PAC-19 QoL.
read more
Delphi, non-RAND modified Delphi, RAND/UCLA appropriateness method and a novel group awareness and consensus methodology for consensus measurement: A systematic literature review
read more
Covid-19 Interventional Clinical Trials Analysis – 04/05/2020
Since Monday 27th April 2020, a further 217 clinical studies were registered using #coronavirus and its synonyms #coronaviruss, #covid19, #sarscov2, #2019ncov etc. by the end of Monday 4th May, an increase of 25%, ..
read more
Covid-19 Interventional Clinical Trials Analysis – 27/04/2020
Since Monday 20th April 2020, a further 212 clinical trials were registered using #coronavirus and its synonyms #coronaviruss, #covid19, #sarscov2, #2019ncov etc.) by the end of Monday 27th April, taking the current total to 851.
read more
Covid-19 Interventional Clinical Trials Analysis – 20/04/2020
Since Monday 13th April 2020, a further 211 clinical trials were registered using #coronavirus and its synonyms #coronaviruss, #covid19, #sarscov2, #2019ncov etc.) by the end of Monday 20th April, taking the current total to 639.
read more
Covid-19 Interventional Clinical Trials Analysis – 13/04/2020
Since Medialis Ltd analysed the clinicaltrials.gov website on Monday 6th April 2020, a further 114 clinical trials were registered using #coronavirus and its synonyms (coronavirus, covid19, sarscov2, 2019ncov etc.)
read more